|
Market Cap (5-Jul) $617,755,968 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 19 February 2021, 9:46. The announcement is not marked as price sensitive, and is 26 page(s) in length and 4MB in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.327% short sold according to ASIC data. It was ranked the 327th most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| Presentation - Dermatology Drug Development Summit Europe | 19 February 2021, 9:46 |
| Botanix receives A$6.87m R&D Tax Incentive Refund | 12 February 2021, 8:20 |
| Phase 2a Study Shows BTX 1801 Eradicates S. Aureus | 3 February 2021, 9:24 |
| Trading Halt | 1 February 2021, 9:49 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 